Literature DB >> 12865965

Aqueous kava extracts do not affect liver function tests in rats.

Yadhu N Singh1, Ashwini K Devkota.   

Abstract

Kava ( Piper methysticum Forst. f., Piperaceae), prepared as the traditional aqueous infusion, was tested in the rat for possible effects on liver function tests. Extracts were administered in daily dosages of 200 or 500 mg of the active kavalactones/kg for two or four weeks. Sera were assayed for four enzymes that are markers of liver toxicity and liver homogenates for malondialdehyde formation that indicates changes in lipid peroxidation. The data showed that none of the enzymes, alanine aminotransferase, aspartate aminotransferase, alkaline phosphatase, and lactate dehydrogenase, nor malondialdehyde were elevated, in fact in some cases they were significantly reduced, suggesting the lack of a toxic effect by kava on the liver.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12865965     DOI: 10.1055/s-2003-40658

Source DB:  PubMed          Journal:  Planta Med        ISSN: 0032-0943            Impact factor:   3.352


  9 in total

1.  Immunohistochemical analysis of expressions of hepatic cytochrome P450 in F344 rats following oral treatment with kava extract.

Authors:  Natasha P Clayton; Katsuhiko Yoshizawa; Grace E Kissling; Leo T Burka; Po-Chuen Chan; Abraham Nyska
Journal:  Exp Toxicol Pathol       Date:  2006-10-23

2.  Liver toxicity and carcinogenicity in F344/N rats and B6C3F1 mice exposed to Kava Kava.

Authors:  Mamta Behl; Abraham Nyska; Rajendra S Chhabra; Gregory S Travlos; Laurene M Fomby; Barney R Sparrow; Milton R Hejtmancik; Po C Chan
Journal:  Food Chem Toxicol       Date:  2011-08-18       Impact factor: 6.023

3.  Kavalactone content and chemotype of kava beverages prepared from roots and rhizomes of Isa and Mahakea varieties and extraction efficiency of kavalactones using different solvents.

Authors:  Jun Wang; Weiyue Qu; Harry C Bittenbender; Qing X Li
Journal:  J Food Sci Technol       Date:  2013-06-25       Impact factor: 2.701

4.  Flavokawain B, the hepatotoxic constituent from kava root, induces GSH-sensitive oxidative stress through modulation of IKK/NF-kappaB and MAPK signaling pathways.

Authors:  Ping Zhou; Shimon Gross; Ji-Hua Liu; Bo-Yang Yu; Ling-Ling Feng; Jan Nolta; Vijay Sharma; David Piwnica-Worms; Samuel X Qiu
Journal:  FASEB J       Date:  2010-08-09       Impact factor: 5.191

5.  The Kava Anxiety Depression Spectrum Study (KADSS): a randomized, placebo-controlled crossover trial using an aqueous extract of Piper methysticum.

Authors:  J Sarris; D J Kavanagh; G Byrne; K M Bone; J Adams; G Deed
Journal:  Psychopharmacology (Berl)       Date:  2009-05-09       Impact factor: 4.530

6.  Enhanced efficacy and reduced side effects of diazepam by kava combination.

Authors:  Rasha A Tawfiq; Noha N Nassar; Wafaa I El-Eraky; Ezzeldein S El-Denshary
Journal:  J Adv Res       Date:  2013-08-22       Impact factor: 10.479

7.  Dietary feeding of Flavokawain A, a Kava chalcone, exhibits a satisfactory safety profile and its association with enhancement of phase II enzymes in mice.

Authors:  Xuesen Li; Xia Xu; Tao Ji; Zhongbo Liu; Mai Gu; Bang H Hoang; Xiaolin Zi
Journal:  Toxicol Rep       Date:  2014

Review 8.  Hepatotoxicity Induced by "the 3Ks": Kava, Kratom and Khat.

Authors:  Flaminia Pantano; Roberta Tittarelli; Giulio Mannocchi; Simona Zaami; Serafino Ricci; Raffaele Giorgetti; Daniela Terranova; Francesco P Busardò; Enrico Marinelli
Journal:  Int J Mol Sci       Date:  2016-04-16       Impact factor: 5.923

9.  Isolation and Purification of Potent Growth Inhibitors from Piper methysticum Root.

Authors:  Truong Mai Van; Tran Dang Xuan; Truong Ngoc Minh; Nguyen Van Quan
Journal:  Molecules       Date:  2018-07-31       Impact factor: 4.411

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.